New imaging technique could reveal hidden clot sources in stroke
NCT ID NCT05636748
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new PET scan tracer called 18F-GP1 that sticks to activated platelets in blood clots. Researchers will scan 120 adults who recently had an ischemic stroke to see if they can find where clots are coming from. The goal is to better understand different types of stroke and improve how doctors diagnose the cause.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
18F-GP1 (a radioactive tracer that binds to activated platelets in blood clots)
What this could lead to
If successful, this imaging technique could help doctors identify the source of blood clots in stroke patients, leading to more targeted treatments.
What could go wrong
This is an early imaging study with only 120 participants, so it may not change clinical practice. The tracer may not detect all types of clots, and results may not apply to all stroke patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Research Facility
RECRUITINGEdinburgh, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••